The results of our studies examining the impact of modulating STAT3 activity, genetically or pharmacologically, in all three cell compartments suggest a dominant role for STAT3 within the T cell compartment in the pathogenesis of DSS-induced colitis. This evidence concerns the gene STAT3 and colitis.